Metraipolis › archive › dc_bb7f95c8baea

Case Report: Dual resistance to dasatinib/olverembatinib in accelerated-phase cml: identification of a novel SPECC1L-inserted e8a2 BCR::ABL1 transcript and… — Europe PMC PMID:41211450

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41211450
DOI: 10.3389/fonc.2025.1711888
License (as archived): solo-consultazione
Archived: 2026-11-09T01:57:01.027Z
SHA-256 of the archived text: dd40f9e992f001cbb4c43a253a202651e19777d508482de76678a1606ccc9a52
Stable URL of this page: https://metraipolis.com/documento/dc_bb7f95c8baea

How to cite

Case Report: Dual resistance to dasatinib/olverembatinib in accelerated-phase cml: identification of a novel SPECC1L-inserted e8a2 BCR::ABL1 transcript and… — Europe PMC PMID:41211450 — Europe PMC (en), https://europepmc.org/article/MED/41211450 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb7f95c8baea (Metraipolis archive dc_bb7f95c8baea, sha256 dd40f9e992f001cbb4c43a253a202651e19777d508482de76678a1606ccc9a52)

BibTeX

@misc{dcbb7f95c8baea,
  title = {Case Report: Dual resistance to dasatinib/olverembatinib in accelerated-phase cml: identification of a novel SPECC1L-inserted e8a2 BCR::ABL1 transcript and… — Europe PMC PMID:41211450},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41211450},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb7f95c8baea; sha256 dd40f9e992f001cbb4c43a253a202651e19777d508482de76678a1606ccc9a52},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41211450. Agents can read the archived copy with the MCP tool read_document.